HIMS is trading at $29.81 (+5%) in pre-market action, building on last week's 10% gain as investors anticipate the company's Q1 2026 earnings report scheduled for May 11.
- Analysts expect revenue of $616.9M and an EPS of $0.04, with the market focused on strategic updates regarding the company's weight-loss offerings.
- The stock is showing strength despite slightly lower pre-market futures, suggesting the move is driven by company-specific anticipation rather than broader market trends.
- Investors are closely monitoring how the company plans to navigate intensifying competition in the telehealth and weight-loss space from giants like Amazon and Eli Lilly.